Scotland Community Pharmacists Will Distribute Molnupiravir to High-Risk Patients

Consumer

The government has stated that community pharmacists in Scotland would be given £45 per item to distribute antiviral molnupiravir to patients in need to treat Covid 19. They would potentially shell out an additional £12 to expense travel when delivering to a patient's home.

A written statement of government policy has stated that “Health Boards may seek to utilise part of the community pharmacy network for the safe and effective dispensing and home delivery of molnupiravir, and any future COVID-19 antivirals, to individuals who are suitable for treatment.”

“The government has stated that community pharmacists in Scotland would be given £45 per item to distribute antiviral molnupiravir to patients in need to treat Covid 19“

The Royal Pharmaceutical Society’s president, Claire Anderson, expressed that as a group they “would support community pharmacies across the whole of Great Britain being commissioned to dispense molnupiravir, as is the case in Scotland. Community pharmacies can provide convenient access to the medicine, especially as these treatments need to be administered as soon as practically possible after receiving a positive PCR test and symptom onset.”

England has taken a different approach to Scotland, with Covid 19 treatment for those at considerable risk being distributed via delivery units rather than community pharmacies. The process is such that they are “dropped off to a patient’s home, either via a friend or family member of the patient, or via a delivery service.”

Wales also has their own way of delivering molnupiravir, with the medication “supplied directly by the National Antiviral Service or in some cases from hospital pharmacy departments.”

© Copyright 2010-2021 Zenopa LTD. All Rights Reserved.

See all the latest jobs in Consumer
Return to news